In line with strategic ambitions, BioMar continues to drive organic business growth with solid earnings and a stable return on invested capital. Overall, ROIC continues to stay in line with the record year 2024, while cash flow from operations is improved substantially.

BioMar’s record sales volumes and earnings momentum continued into Q2, where volumes sold in the second quarter increased by 14% year on year with contributions from all feed segments. A healthy EBITDA was maintained, while preparing for the high season in Q3. Overall, the results confirm the expectations for a good full-year result.

“As a part of our strategic commitment to growth, we have successfully continued the increase in sales volumes in Q2, reinforcing value-creating partnerships with key customers across our markets. I am proud to witness that this growth was achieved with healthy profitability, improved cash flow and a solid ROIC.

As expected, a change in customer mix towards large customers with larger volumes impacted profit measured per tonne, while we continue our focus on achieving the critical volumes to be efficient and competitive, while optimising our cash discipline”, explains Carlos Diaz, CEO, BioMar Group.

EBITDA is reported at DKKm 349, which is lower than the exceptionally good Q2 2024 at DKKm 361, mainly due to larger feed volumes with large customers. The non-consolidated joint venture feed companies in China and Turkey have reported an EBITDA for the quarter at DKKm 48 against DKKm 64 in Q2 2024.

“We have prepared for this ramp-up by strengthening the commercial and operational excellence of the company, reflected in last year's record earnings. We continue to be on track, rebalancing growth, and I am with great expectations looking forward to the rest of 2025”, concludes Carlos Diaz.

ROIC including goodwill stays attractive at 19.6% on 30 June 2025, compared to 19.8% on 30 June 2024. Cash flow from operating activities for Q2 amounts to DKKm 249, compared to DKKm 116 in Q2 2024. The improvement is primarily due to new initiatives within cash discipline

BioMar expects to generate full-year 2025 revenue of about DKK 16.3-17.0 billion compared to previous guidance at DKK 16.0-17.0 billion, but changing market conditions and volatile prices of raw materials may as always impact the revenue forecast substantially. Due to the result for H1 and the expectations to H2 2025, BioMar is increasing its EBITDA guidance to DKKm 1,490-1,570 from previous DKKm 1,470-1,570.